BACKGROUND AND PURPOSE The sole Food and Drug Administration-approved treatment for stroke is tissue-type plasminogen activator (tPA), but its brief therapeutic window and complications of treatment constrain its use. One limitation may be its potential to exacerbate impairment of cerebral autoregulation after stroke. Vasodilation is maintained by elevations in cAMP. However, cAMP levels fall a...

299 How to cite this article: Abreu Velez AM, Jackson BL, Howard MS. Intraepidermal and subepidermal blistering with skin necrosis, possibly caused by etanercept in treatment of a patient with psoriasis. Our Dermatol Online. 2015;6(3):299-303. Submission: 22.01.2015; Acceptance: 12.03.2015 DOI:10.7241/ourd.20153.80 Intraepidermal and subepidermal blistering with skin necrosis, possibly caused b...

(4) Pigmentation of Polymita picta (5) Pigmentation of Cepaea nemoralis (6) Conclusion . . . . . . . . (2) General characters of helicid pigmentation . . (3) Colour associations and interchangeability of pigments . . . . . . . . V. Summary . . . . . . . . . VI. References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . PAGE 285 286 288 288 289 289 292 2...

From October 2010 to December 2015, we screened a total of 1716 babies. 809 babies were from well-baby nurseries and 907 babies were from neonatal intensive care unit. 299 babies failed the first screen, but only 66 out of 299 appeared for rescreen. Eighteen babies failed the rescreen and were recommended BERA testing. However, none of the babies turned up for BERA testing or could not be track...